Growth Stock Wire Investment Newsletter

 
Growth Stock Wire Investment Newsletter About Growth Stock Wire Frequently Asked Questions Growth Stock Wire Archives Contact Us Privacy Policy
Print Edition | Sponsored Link:

CSI: Wall Street
By Jeff Clark
June 7, 2007

You've seen them on television – those crime scene investigators who can catch bad guys by simply studying a piece of bubble gum stuck to the bottom of a Chinese take-out box.

I had lunch with a real-life version of a CSI yesterday afternoon.

Steve is a homicide detective in San Francisco. He's been catching criminals for more than 20 years, and – as you might imagine – he has a ton of stories.

"It's all about noticing inconsistencies," he said. "You know, the little stuff that no one else sees." Steve went on to tell me about a recent case where he noticed a small line in the dust on a bookshelf. The line was about the same width as one of the picture frames on the shelf, and he figured the picture had been moved recently. So he dusted the frame for fingerprints. And that led him to the murderer.

Tiny evidence led him to a big break in a criminal case. And, in that respect, Steve is a lot like a successful Wall Street trader.

In trading, just as in solving crimes, it's all about noticing the inconsistencies. Noticing stocks that behave well in the face of bad news can lead to profitable opportunities. Watching how shares of Merrill Lynch perform can provide clues as to the immediate direction of the broad stock market.

And looking for stocks that go up in the midst of a strong stock market selloff may give us a big break for next week.

Let me explain...

Stocks that perform well during market corrections often lead the market during the next rally phase. And stocks that suffer through a long period of decline and then turn higher during a broad market selloff experience the largest gains.

During yesterday's 129 point drubbing of the Dow, there were 2,675 stocks that lost ground on the New York Stock Exchange; 625 stocks went up.

If you get rid of all the exchange traded funds, all the income-oriented stocks, and all the "news related" rally stocks, then you trim yesterday's list of gainers down to about 250 issues. If you narrow the list further to include only those stocks that are less than 20% above their 52-week lows, then you're down to about 60 names.

And if you search that list for stocks that rallied during Tuesday's decline as well, then you have just 17 possible suspects – 17 stocks that could be the best performers during the next rally phase of the stock market.

Will I be sharing any of these ideas with you?

Before I answer that question, let me whip off my sunglasses, tilt my head a bit, squint my eyes and look halfway down at the ground – and in my best David Caruso impression, reply:

"I guess we'll know soon enough. Won't we?"

Cue theme music.

Best regards and good trading,

Jeff Clark

Mutual Funds Won’t Touch ETFs
Barclays Global Investors is struggling to break into the $2.4 trillion 401(k) market because the biggest U.S. retirement-plan managers won't offer exchange-traded funds, the company's hottest-selling product.

Barclays Global is the world's largest ETF manager, with assets increasing an average 86 percent annually in the past six years to $363 billion. Less than 1 percent of the San Francisco- based company's exchange-traded funds are in 401(k) retirement plans. Read on...

Spanish Real Estate Takes a Plunge
Javier Usua and Ruth Graneda never got out of the car when they visited Sanchinarro and Las Tablas, two of Madrid's biggest new suburban developments. The concrete-block buildings and empty streets were all they needed to see.

We came to look at apartments but found ghost towns," said Usua, a 27-year-old taxi driver. "You'd need to drive miles for a loaf of bread or cigarettes and my girlfriend found it creepy and unsafe so we turned around and left." Read on...


America's second largest ethanol producer, VeraSun Energy, hits new lows on fears of exploding ethanol production.

$80 billion biotech Genentech hits new 52-week low on lung cancer drug weakness.

Asian blue chips China Telecom Corp, Millea Holdings, Kyocera, and Mitsui & Co hit new 52-week highs.

Discount broker TD Ameritrade hits new high on activist investor pressure.

Last Change 52-Wk
S&P 500 1530.95 -0.53% 21.00%
Oil (USO) 50.02 -0.66% -27.23%
Gold (GLD) 66.37 -0.26% 4.87%
Silver (SLV) 137.00 0.38% 13.30%
US Dollar 81.91 -0.11% -2.88%
Euro 1.352 0.14% 4.87%
VIX 13.63 2.56% -18.14%
HUI 339.99 -0.74% 3.63%
10-year yield 4.98% 0.05 -0.05

Advertisement
 

Company Sym Industry

Post Properties

PPS

apartment REIT

Regal Entertainment

RGC

movie theaters

Vina Concha y Toro

VCO

wine

Nikkei 225 MITTS

NKS

MITTS

China Telecom Corp

CHA

telecom

Meredith

MDP

publishing

Sharper Image

SHRP

retail

United States Steel

X

steel

Mitsui & Co

MITSY

conglomerate

Apple

AAPL

computers

Guess?

GES

clothing

Shutterfly

SFLY

online photos

Kyocera

KYO

electronics

CBS

CBS

broadcasting

Perini

PCR

construction

Millea Holdings

MLEA

insurance

Dollar Tree Store

DLTR

discount retail

ITT Education

ESI

secondary edu

TD Ameritrade

AMTD

online broker

Natural Gas Srvcs

NGS

gas services

DCP Midstream

DPM

oil & gas pipeline

Company Sym Industry

Oilsands Quest

BQI

mining

La-Z-Boy

LZB

furniture

sonicWALL

SNWL

networks

Genentech

DNA

biotech

iPCS

IPCS

telecom

Hovnanian HOV homebuilder
Southwest Air LUV airlines
Travelzoo TZOO online travel
VeraSun Energy VSU ethanol

Halliburton Isn't the Only One
June 06, 2007

The Magic Formula for Stock Picking
June 05, 2007

The Insiders Are Buying For Income
June 04, 2007

Weekend Edition: The Best of The S&A Digest
June 02, 2007

The Absolute Best Way to Buy Small Mining Stocks
June 01, 2007

Home | About GSW | FAQ | GSW Archive | Privacy Policy | Contact Us

Customer Service: 1-888-261-2693 – Copyright 2008 Stansberry & Associates Investment Research. All Rights Reserved. Protected by copyright laws of the United States and international treaties. This e-letter may only be used pursuant to the subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of Stansberry & Associates Investment Research, LLC. 1217 Saint Paul Street, Baltimore MD 21202